Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/1995
10/31/1995US5462942 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT 1A-antagonistic activity
10/30/1995CA2148053A1 Non-peptidyl tachykinin receptor antagonists
10/29/1995CA2147925A1 Pseudopeptides derived from neurokinins; process for preparing the same and pharmaceutical compositions containing them
10/28/1995CA2147930A1 Use of substituted amines for the treatment of brain function disorders
10/26/1995WO1995028493A1 Aav-mediated delivery of dna to cells of the nervous system
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028480A1 Methods of use of uncoated gel particles
10/26/1995WO1995028474A1 Dna encoding bradykinin b1 receptor
10/26/1995WO1995028419A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/26/1995WO1995028418A2 Tachykinin antagonists
10/26/1995WO1995028403A1 Abeo-ergoline derivatives as 5ht1a ligands
10/26/1995WO1995028401A1 Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors
10/26/1995WO1995028399A1 A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds
10/26/1995WO1995028151A1 Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2187526A1 Methods of use of uncoated gel particles
10/26/1995CA2186900A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/26/1995CA2183991A1 Tachykinin antagonists
10/26/1995CA2163773A1 Abeo-ergoline derivatives as 5ht1a ligands
10/25/1995EP0678503A1 Delta-amino-gamma-hydroxy-omega-aryl alkanoic acid amides with enzyme especially renin inhibiting activities
10/25/1995EP0678099A1 New peptides
10/25/1995EP0678098A1 Pyrrolidine and thiazolidine derivatives, their preparation and drugs containing same
10/25/1995EP0678090A1 Piperazine derivatives
10/25/1995EP0678089A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
10/25/1995EP0678088A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
10/25/1995EP0678026A1 Application of carbamazepine and oxcarbazepine in the treatment of parkinson's disease and parkinsonian syndromes.
10/25/1995EP0678024A1 Use of idazoxan and its derivatives in the treatment of alzheimer-type senility
10/25/1995EP0678023A1 Application of riluzole in the treatment of parkinson's disease and parkinsonian syndromes.
10/25/1995EP0678021A1 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex
10/25/1995EP0598765B1 2-aminonaphthyridine derivative, its preparation and use
10/25/1995EP0406413B1 Scanning type tunnel microscope
10/24/1995US5461156 Stereocontrolled synthesis of cis-bicyclic compounds
10/24/1995US5461146 Enzyme inhibitor protecting nerve cells from degeneration
10/24/1995US5461062 Condensed imidazopyridine derivatives
10/24/1995US5461061 Antidepressants
10/24/1995US5461047 2-,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use
10/24/1995US5460826 Morphine therapy
10/24/1995US5460605 Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
10/24/1995CA2006404C Transdermal therapeutical system comprising physostigmine as component and process for the production thereof
10/24/1995CA1337429C Derivatives of 2,2'-iminobisethanol
10/24/1995CA1337421C 1-indolylalkyl-4-(substituted-pyridinyl)piperazines
10/24/1995CA1337418C 4-aryl-4-piperiding (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
10/24/1995CA1337417C Pyridyl- and pyrimidyl derivatives
10/24/1995CA1337415C Indole derivatives
10/19/1995WO1995027793A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II)
10/19/1995WO1995027792A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICErel-III)
10/19/1995WO1995027723A1 Receptor modulating agents and methods relating thereto
10/19/1995WO1995027713A1 Process for the resolution of etodolac using glucamine derivatives
10/19/1995WO1995027712A1 Novel spiro[indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as a drug
10/19/1995WO1995027511A1 NEW COMBINATION OF A β-RECEPTOR BLOCKER AND A LOCAL ANAESTHETIC
10/19/1995WO1995027502A1 Method of treating auto-immune diseases using type one interferons
10/19/1995WO1995027499A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995WO1995027496A1 Vasoactive intestinal polypeptide
10/19/1995WO1995027490A1 Use of serotonin antagonists (5ht3) for treating fibromyalgia
10/19/1995WO1995017904A3 Botulinum toxins for treating various disorders and associated pain
10/19/1995CA2187550A1 Method of treating auto-immune diseases using type one interferons
10/19/1995CA2187322A1 Vasoactive intestinal polypeptide
10/19/1995CA2185353A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/18/1995EP0677517A1 Treatment of Alzheimer's disease employing inhibitors of cathepsin D
10/18/1995EP0677516A1 Cyclic amide derivatives
10/18/1995EP0677514A1 New cyclopropyl derivatives, preparation method thereof and applications
10/18/1995EP0677290A1 Percutaneous preparation comprising tulobuterol
10/18/1995EP0677100A1 Method for production of neuroblasts
10/18/1995EP0677051A1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
10/18/1995EP0677042A1 Selective ligands of receptors 5-ht 1d?-5ht 1b? derived from indole-piperazine useful as medicaments
10/18/1995EP0676961A1 Use of macrolides for the treatment of cerebral ischemia
10/18/1995CN1110470A Novel anxiolytic
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1110143A Oligosaccharid type antipsychotic
10/17/1995US5459270 Tachykinin antagonist for central nervous systum disorders and cardiovascular disorders
10/17/1995US5459156 Angiotensin converting enzyme inhibitors, hypotensive, atherosclerosis
10/17/1995US5459153 Composition and methods for treatment of acne vulgaris and for retardation of aging
10/17/1995US5459138 Dysfunctions of glutamatergic neurotransmission associated with learning and memory
10/17/1995US5459137 Muscle relaxants, anticonvulsants, neuroprotective agents
10/17/1995US5459036 Extracellular signal-regulated kinase, sequences, and methods of production and use
10/17/1995CA2001671C Aqueous elcatonin solution composition
10/17/1995CA1337352C Substituted propane-phosphinic acid compounds
10/17/1995CA1337351C Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
10/17/1995CA1337348C Optically active 20,21-dinoreburnamenin derivatives; process for preparing the same; use thereof as drugs and pharmaceutical compositions containing them
10/17/1995CA1337347C Benzimidazoline-2-one-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
10/12/1995WO1995027066A2 Dna encoding ubiquitin conjugating enzymes
10/12/1995WO1995026973A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995WO1995026957A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
10/12/1995WO1995026739A2 Use of substituted dextranes for treating nervous system damage, and heparane sulphate-enriched fractions
10/12/1995WO1995026723A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995WO1995026716A1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments
10/12/1995WO1995026713A1 Heterofunctional, mucoadhesive dosage form
10/12/1995WO1995025509A3 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity
10/12/1995CA2187166A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995CA2186863A1 Heterofunctional, mucoadhesive dosage form
10/12/1995CA2186636A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/11/1995EP0676411A2 Peptides and pseudopeptides derived from tachykinine, their preparation and their pharmaceutical compositions
10/11/1995EP0676395A2 Substituted N-heteroaroylguanidines, as inhibitors of sodium-hydrogen exchange, as antiarrhythmic agents and as inhibitors of the proliferation of cells
10/11/1995EP0676205A1 Cerebral metabolism activator containing glucose ester derivative
10/11/1995EP0676203A1 Pharmaceutical compositions of antiglucocorticoid compounds for treating or preventing symptoms of spontaneous or narcotic-induced withdrawal
10/11/1995EP0676200A2 Use of eliprodil and of its enantiomers in the preparation of medicaments for the treatment of peripheral neuropathies and or central neurodegenerative diseases
10/11/1995EP0675961A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/11/1995EP0675902A1 Endothelin antagonists
10/11/1995EP0675901A1 Difluoro-pentapeptide derivative anti-inflammatory agents
10/11/1995EP0675896A1 Purine derivatives
1 ... 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 ... 1833